Additional Information

Description

Privigen, 10% (40000 mg), is an intravenous immunoglobulin (IVIg) product designed for the treatment of various immunodeficiencies and autoimmune disorders. It is formulated with human immunoglobulin G (IgG) derived from pooled plasma of healthy donors. Privigen provides a high concentration of IgG to help restore the immune system in patients with deficiencies or dysfunctions of their antibody production.

Privigen is primarily used in the treatment of primary humoral immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIDP). It is also indicated for the treatment of acute immune thrombocytopenic purpura (ITP) and other autoimmune conditions, where immune modulation is required. 

Privigen is administered intravenously under medical supervision, with the dosage and infusion rate tailored to the patient’s specific needs. The preservative-free formulation minimizes the risk of side effects, providing a safer treatment option for long-term use. Its effectiveness in modulating the immune system makes it an essential option for patients with compromised immune function.